Clinical Trial Update: A Phase 1/2 Study of GW5282 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating GW5282 in participants with advanced solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• GW5282 (GW5282)

Snippet

Sponsor: Dizal Pharmaceuticals | Conditions: Advanced Solid Tumors | Phase 1, Phase 2 | Status: RECRUITING